Literature DB >> 23446097

Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia.

María Paz Garcia-Portilla1, Pilar Alejandra Saiz, Manuel Bousoño, María Teresa Bascaran, Carlos Guzmán-Quilo, Julio Bobes.   

Abstract

INTRODUCTION: The main long-term therapeutic goals of schizophrenia should go beyond the symptoms and include the improvement of patients' psychosocial functioning and quality of life. The aim of this study was to validate the Personal and Social Performance (PSP) scale in Spanish outpatients with schizophrenia.
MATERIALS AND METHODS: Naturalistic, 6-month follow-up, multicentre study. 244 patients and 76 controls were evaluated using the PSP, the Social and Occupational Functioning Assessment Scale (SOFAS), and the Clinical Global Impression - Severity (CGI-S) and Change (CGI-C) scales.
RESULTS: Internal reliability=0.87. Test-retest reliability=0.98. Construct validity=1 component that explained 73.2% of the variance. Convergent validity: Pearson correlation coefficient between PSP and SOFAS=0.95 (p<0.0001), between PSP and CGI-S=-0.88 (p<0.0001). Discriminant validity: the PSP discriminates between patients and controls [50.3 versus 91.9, p<0.0001] and among patients with mild, moderate, and severe schizophrenia according to CGI-S scores [73 versus 56.6 versus 37.5, p<0.0001]. Area under the curve=0.986. A cut-off point of 79 on the PSP scale provided good sensitivity (94.3%) and specificity (96.1%) for identifying patients and controls according to their level of functioning. At month 6 significant improvements (p<0.0001) were seen in PSP, SOFAS, and CGI-C scores. The PSP was sensitive to improvement; a score of very much improved in the CGI-C corresponds to a improvement of 34 points in the PSP.
CONCLUSION: The Spanish PSP is a reliable, valid and sensitive instrument for measuring functioning in outpatients with schizophrenia. As a brief, clinician-rated instrument, the PSP scale seems to be appropriate for use in everyday clinical practice as a mean of identifying and monitoring changes in patient's functioning.
Copyright © 2010 SEP y SEPB. Published by Elsevier Espana. All rights reserved.

Entities:  

Year:  2011        PMID: 23446097     DOI: 10.1016/j.rpsm.2010.11.003

Source DB:  PubMed          Journal:  Rev Psiquiatr Salud Ment        ISSN: 1888-9891            Impact factor:   3.318


  8 in total

1.  The Effects of Metacognition-Oriented Social Skills Training on Psychosocial Outcome in Schizophrenia-Spectrum Disorders: A Randomized Controlled Trial.

Authors:  Felix Inchausti; Nancy V García-Poveda; Alejandro Ballesteros-Prados; Javier Ortuño-Sierra; Sergio Sánchez-Reales; Javier Prado-Abril; José Antonio Aldaz-Armendáriz; Joe Mole; Giancarlo Dimaggio; Paolo Ottavi; Eduardo Fonseca-Pedrero
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

2.  Needs, Perceived Support, and Hospital Readmissions in Patients with Severe Mental Illness.

Authors:  Jose Guzman-Parra; Berta Moreno-Küstner; Fabio Rivas; Mercedes Alba-Vallejo; Javier Hernandez-Pedrosa; Fermin Mayoral-Cleries
Journal:  Community Ment Health J       Date:  2017-02-07

3.  Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Ruth Lorente-Omeñaca; Lucía Moreno-Izco; Victor Peralta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-09-07       Impact factor: 5.270

4.  Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial.

Authors:  Roberto Mediavilla; Ainoa Muñoz-Sanjose; Beatriz Rodriguez-Vega; Carmen Bayon; Angela Palao; Guillermo Lahera; Pilar Sanchez-Castro; Eva Roman; Susana Cebolla; Alvaro de Diego; Juan Manuel Pastor; Maria Fe Bravo-Ortiz
Journal:  BMC Psychiatry       Date:  2019-07-29       Impact factor: 3.630

5.  Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.

Authors:  Meritxell Fernández-Lafitte; Jesus Cobo; Ramon Coronas; Isabel Parra; Joan Carles Oliva; Aida Àlvarez; Susanna Esteba-Castillo; Olga Giménez-Palop; Diego J Palao; Assumpta Caixàs
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241

6.  Efficacy of nutrition education for the increase of symbiotic intake on nutritional and metabolic status in schizophrenic spectrum disorders: A two-arm protocol.

Authors:  Alfonso Sevillano-Jiménez; Guillermo Molina-Recio; Juan Antonio García-Mellado; María García-Rodríguez; Rafael Molina-Luque; Manuel Romero-Saldaña
Journal:  Front Nutr       Date:  2022-08-10

7.  Free Thyroxine Concentrations Moderate the Response to a Cognitive Remediation Therapy in People With Early Psychosis: A Pilot Randomized Clinical Trial.

Authors:  Francesc Estrada; Josep Maria Crosas; Maribel Ahuir; Sara Pérez-Muñoz; Wanda Zabala; Raquel Aguayo; Juan David Barbero; Itziar Montalvo; Meritxell Tost; Laura Llauradó; Armand Guardia; Diego Palao; José Antonio Monreal; Javier Labad
Journal:  Front Psychiatry       Date:  2020-07-07       Impact factor: 4.157

8.  Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI).

Authors:  Susana Al-Halabí; Pilar A Sáiz; Marlén Garrido; Gonzalo Galván; María José Casares; María Teresa Bobes-Bascarán; Eva M Díaz-Mesa; Patricia Burón; Leticia García-Álvarez; Javier Suárez-Álvarez; José Muñiz; M Paz García-Portilla; Julio Bobes
Journal:  Int J Clin Health Psychol       Date:  2015-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.